
Sugentech
Innovative diagnostic solutions for healthcare, featuring automated immunoblot systems and advanced biosensors.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Post IPO Equity | |
Total Funding | 000k |
KRW | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | (29 %) | 975 % | 87 % | 31 % | (93 %) | 42 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (75 %) | (168 %) | 57 % | 47 % | 28 % | (188 %) | (125 %) |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (751 %) | (249 %) | (99 %) | 47 % | 26 % | (242 %) | (150 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | - | 8 % | 5 % | 5 % | 51 % | 46 % |
Source: Company filings or news article
Related Content
Sugentech is a healthcare technology company specializing in diagnostic solutions. The company develops and manufactures advanced diagnostic devices, including the world's first fully automated multi-immunoblot system, which is used by general hospitals and examination centers. Sugentech operates in the medical diagnostics market, serving healthcare providers who require accurate and efficient diagnostic tools. The business model is based on the sale of diagnostic equipment and related consumables, generating revenue through product sales and ongoing supply contracts. The company aims to improve healthcare outcomes by providing innovative and reliable diagnostic solutions.
Keywords: diagnostic solutions, healthcare technology, immunoblot systems, biosensors, medical diagnostics, automated systems, healthcare providers, diagnostic equipment, consumables, innovative healthcare.